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Abstract
The rate and extent of membrane fusion is markedly sensitive to membrane interfacial properties. Lipopeptides with
hydrophilic peptide moieties will insert into membranes, leaving the peptide portion at the membrane-water interface. In this
w 15 x  .work, we have used a lipopeptide composed of the peptide Nle -gastrin- 2–17 -amide covalently linked to 1,2-diacyl-3-
mercaptoglycerol-N a-maleoyl-b-alanine to give DM-gastrin or DP-gastrin having 14 or 16 carbon atom acyl chains,
respectively. The fluorescence emission from the two Trp residues of these lipopeptides exhibited little or no blue shift upon
addition of liposomes of egg-phosphatidylethanolamine containing 5 mol% G . Iodide quenching of DP-gastrin fluores-D1a
cence was also independent of lipid. These results indicate that the peptide moiety is exposed to the aqueous environment
even though the lipopeptide is firmly anchored to the membrane. Both DM and DP-gastrin markedly raise the bilayer to
hexagonal phase transition temperature of dipalmitoleoyl phosphatidylethanolamine. However, DM-E lowers this phase5
transition temperature. These lipopeptides have effects on the overall fusion of Sendai virus to liposomes in accord with
their opposite effects on lipid curvature. The lipogastrins are potent inhibitors of viral fusion, while DM-E slightly5
promotes this process. Truncated forms of DM-gastrin are also inhibitory to viral fusion, but are less inhibitory than the full
lipopeptide. Analysis of the fusion kinetics shows that DP-gastrin causes a reduction in the final extent of fusion and a
marked lowering of the fusion rate constant. Binding of Sendai virus to the ganglioside receptor-containing liposomes was
not affected. Consideration of the various contributions to the mechanism of inhibition of viral fusion suggests that effects
of lipogastrin on membrane intrinsic monolayer curvature is of primary importance. q 1997 Elsevier Science B.V.
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1. Introduction
Lipidation of peptides with a double chain lipid
anchor firmly attaches the lipopeptide to the mem-
w xbrane 1 . This can allow the placement of specific
binding sites on a membrane surface. In addition,
there will be non-specific effects resulting from the
lipopeptide altering the physical properties of the
membrane. The lipopeptide, a-factor, has been found
to raise the bilayer to hexagonal phase transition
w xtemperature of phosphatidylethanolamine 2 . Many
substances having this property also inhibit viral fu-
w xsion 3 . Membrane fusion is inhibited by making the
contacting membrane interfaces more polar and hy-
drated as well as by expanding the headgroup area of
the outer monolayer so as to produce positive curva-
w xture strain 4 . Lipid-anchored hydrophilic polymers
may be effective agents to inhibit membrane fusion.
These substances will be sequestered to the mem-
brane, but they will also make the membrane inter-
face more polar and expanded. In this work we
explore the non-specific interactions between a
lipopeptide and the fusion of an enveloped virus. We
have studied how several lipid-anchored peptides af-
fect the polymorphism of model membranes and their
fusion with virions. We have used lipopeptides which
have been made by covalently linking a peptide to a
 .lipid anchor containing two acyl chains Fig. 1 . The
acyl chains were either C14 or C16, which are suffi-
ciently long to sequester the lipopeptide in the mem-
brane. The peptides were largely hydrophilic and
therefore stayed at the membrane interface andror in
w xthe aqueous environment above the membrane 5,6 .
A lipid anchored polymer, lipophosphoglycan from
 .Leishmania dono˝ani LPG , has been found to be a
potent inhibitor of the fusion of Sendai virus and
Fig. 1. Structure of the lipid anchor, the di-fatty acyl-thio-
. .glyceryl -succinimidyl propionyl moiety attached to the N-
 .terminus of peptides R .2
w xinfluenza 7 . We wished to explore other
membrane-anchored polymers, to determine if they
also have an effect on viral fusion. The lipopoly-
saccharide, LPG, has a molecular mass of 9500 while
lipopeptides used in this work have a molecular mass
of about 2700 or less. The lipopeptides represent a
class of molecules which are chemically and struc-
turally very different from LPG. In addition these
lipopeptides are smaller than LPG and therefore would
contribute less steric interference to viral fusion. Fur-
thermore, the general strategy of using lipopeptides
as inhibitors of viral fusion provides much flexibility
as to the nature of the tethered peptide.
2. Materials and methods
2.1. Chemicals
All phospholipids were obtained from Avanti Polar
 .Lipids Alabaster, AL, USA . Gangliosides were pu-
w xrified according to Reed et al. 8 . All lipids showed
one spot by TLC at a load of 50 mg. Fluorescent
probes were purchased from Molecular Probes
 .Eugene, OR, USA . Lipogastrins and derivatives
w xwere synthesized as described by Romano et al. 5 .
All other chemicals and solvents were of reagent
grade. The structures of these lipopeptides are given
in Table 1.
2.2. Preparation of large unilamellar ˝esicles
Phospholipid and the ganglioside G were dis-D1a
solved in a solution of chloroformrmethanol, 2r1
 .vrv . The solvent was evaporated with a stream of
dry nitrogen gas, depositing the lipids as a film on the
walls of a Pyrex test tube. Samples were placed in a
vacuum evaporator equipped with a liquid nitrogen
trap for 2–3 h to remove the last traces of solvent.
The dried lipid film was suspended by vigorous
vortexing with 5 mM HEPES, 5 mM MES, 5 mM
sodium citrate, 150 mM NaCl, 1 mM EDTA at pH
 .7.4 HEPESrMES buffer . The lipid suspensions
were further processed with 5 cycles of freezing and
thawing, followed by 10 passes through two stacked
0.1 mm polycarbonate filters Nucleopore Filtration
.Products, Pleasanton, CA, USA using an Extruder
 . w xLipex Biomembranes at room temperature 9,10 .
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Lipid phosphorous was determined by the method of
w xAmes 11 . The lipogastrins were added subsequent
to liposome formation. The lipogastrins are expected
to partition into the liposomes because they are dou-
ble acyl chain amphiphiles which have limited solu-
bility in water. If the lipid partitioning were incom-
plete, this would indicate that the membrane bound
forn of the lipogastrins are actually more potent than
we state. However, this is not likely since Moroder
and colleagues have found that lipogastrin rapidly
w xinserts into liposomes 6 . In addition, we have
demonstrated that the Trp fluorescence from DP-
gastrin changes when LUVs are added but after a few
minutes no further changes are observed.
2.3. Quasi-elastic light scattering
Particle sizing was carried out with a laser light
scattering instrument from Brookhaven Instrument
Corp., equipped with a BI-20sm goniometer, version
2.0 and a BI-900AT Digital Correlator System. Size
distribution analysis was calculated using a non-nega-
tively constrained least squares method, using soft-
ware provided by the instrument manufacturer. Lipo-
some size was found to be approximately 115 nm.
2.4. Virus preparations
The Cantell strain of Sendai virus was propagated
in the allantoic sac of 10-day-old embryonated
chicken eggs by incubation at 338C for 72 h. Virus
was isolated by discontinuous sucrose gradient cen-
trifugation. The virus was washed and the final
preparation was resuspended in HEPES-buffered
saline, pH 7.4 at a viral protein concentration of 1
mgrml. The virus was stored in the frozen state at
y808C.
2.5. Virus fusion assay
Sendai virus was labelled with octadecyl rho-
 .  .damine R18 Molecular Probes, Eugene, OR, USA
w xaccording to the procedure of Hoekstra et al. 12 .
 .Ten microliters of R18 10 nmol in ethanol were
injected into 1 ml of a suspension of Sendai virus in
HEPESrMES buffer containing approximately 1 mg
of viral protein. The mixture was allowed to incubate
at room temperature for 1 h. Unincorporated R18 was
then removed by passing the labelled virus through a
Sephadex G-75 gel filtration column eluted with the
HEPESrMES buffer, and collecting the virus in the
void volume. The final viral protein concentration
was determined using the BCA assay Pierce Chemi-
.cal Co., Rockford, IL, USA . LUVs were diluted into
2 ml of HEPESrMES buffer, pH 7.4 maintained in a
thermostated cuvette holder at 378C with continual
magnetic stirring. Lipogastrins were added to the
liposome suspension and incubated for 10 min. Then
5 mg of R18-labelled Sendai virus was rapidly in-
jected into the cuvette. Fluorescence was recorded
using an SLM AMINCO Bowman Series 2 Lumines-
cence Spectrometer interfaced with a 386r20 IBM
compatible computer. The instrument used a xenon
arc light source with a 560 nm filter between the
excitation slit and sample and a 590 nm cutoff filter
between the sample and the photomultiplier tube to
minimize any contribution of light scattering to the
fluorescence signal. The excitation and emission
monochromators were set at 565 and 600 nm, respec-
tively. The fluorescence intensity immediately after
addition of the labelled virus is taken as F . A 40 ml0
aliquot of 10% Triton X-100 was added in order to
measure F . The percentage of R18 dequenching100
was calculated at time t from:
%Fusions%R18 Dequenching
s100 F yF r F yF .  .t 0 100 0
For kinetic experiments, the fluorescence was
recorded over the first 10 min after addition of the
virus following a 15 min incubation period with
LUV’s and lipopeptides. For the final extents of
fusion, the cuvettes are wrapped in foil and the
fluorescence was measured after 20 h of incubation at
378C in a shaking water bath. The use of a fusion
assay based on membrane mixing requires elimina-
tion of nonspecific probe transfer. The early studies
employing the R18 assay indicated experimentally
that probe transfer was minimal at incubation times
w xof up to 1 h. In Nir et al. 13,16 incubation times of
Sendai virus with liposomes were 24 h. The liposome
concentrations in the latter study varied between 2.5–
50 mM of lipid. Shorter incubation times, such as 8 h
had little effect on the outcome. A model that as-
sumed partial fusion activity could simulate the final
extents quite adequately, whereas a model based on
( )R.F. Epand et al.rBiochimica et Biophysica Acta 1327 1997 259–268262
probe partition fails to explain such results. An exam-
w xple was given later in Larsen et al. 17 for a compari-
son between the ability of these two models to ex-
plain the results of final extents of fluorescence in-
crease. In the current study the model could yield fair
predictions for both the final extents and kinetics of
fluorescence increase for a 4-fold variation in lipid
 .concentration results not shown . Hence, although a
certain degree of probe exchange cannot be ruled out,
it cannot contribute to more than 10% of the total
fluorescence increase. The results in Table 4 demon-
strate about 2-fold reduction in the percentages of
virions capable of fusing when 1.8 mol% of DP-
gastrin was included in the liposomes.
2.6. Analysis of data
The analysis of final extents and kinetics of fusion
of Sendai virus with liposomes was done as previ-
w xously described 13 . In the analysis of the kinetics of
fusion we have employed three parameters: C, the
second order rate constant of virus adhesion to lipo-
somes; f , the first order rate constant of the actual
fusion of an adhered virus particle; D, the first order
dissociation rate constant.
( )2.7. Differential scanning calorimetry DSC
Lipid films were made from dipalmitoleoyl phos-
 .phatidylethanolamine DiPoPE dissolved in chloro-
 .formrmethanol 2r1 vrv . After solvent evaporation
with nitrogen, final traces of solvent were removed in
a vacuum chamber for 90 min. The lipid films were
suspended in 20 mM PIPES, 1 mM EDTA, 150 mM
NaCl with 0.002% NaN , pH 7.40 by vortexing for3
30 s at room temperature. The final lipid concentra-
tion was 10 mgrml. Lipogastrin solutions were pre-
pared by adding 5 ml of NH OH to a weighed4
amount of peptide, then adding HEPESrMES buffer
pH 7.4 to obtain the desired concentration and finally
readjusting the pH to 7.4. Appropriate amounts of
lipogastrins in buffer solution were added to the lipid
and vortexed vigorously. The lipid suspension was
degassed under vacuum before being loaded into an
MC-2 high sensitivity scanning calorimeter Microcal
.Co., Amherst, MA, USA . A heating scan rate of
378Crh was generally employed. The observed phase
transitions were independent of scan rates between 10
and 608Crh. The bilayer to hexagonal phase transi-
tion was fitted using parameters to describe an equi-
librium between two phases, using a single van’t
w xHoff enthalpy 14 . The transition temperature is
reported as that of the fitted curve.
2.8. Tryptophan fluorescence
Fluorescence emission spectra of tryptophan in
lipogastrins, with and without LUV’s of egg PE with
5% G , were measured using an SLM AmincoD1a
Bowman Series II luminescence spectrometer. The
Table 1
Lipopeptide: peptide sequences
Peptide moiety
w xNL-HG 20 pGlu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2
 .w xDM-gastrin 2–17 5 Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2
 .w xDP-gastrin 2–17 5 Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2
a .DM-gastrin 7–17 Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2
a .DM-gastrin 9–17 Glu-Glu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2
a .DM-gastrin 11–17 Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH2
DM-CCK Arg-Asp-Tyr-Gly-Trp-Nle-Asp-Phe-NH2
w xDM-AAe 21 Ala-Ala-D-iso-Glu
bDM-E Glu-Glu-Glu-Glu-Glu5
a .DMs 2 R,S -1,2-dimyristoyl-3-mercaptoglycerol-N -maleoyl-b-alanyl
a .DPs 2R,S -1,2-dimyristoyl-3-mercaptoglycerol-N -maleoyl-b-alanyl
pGluspyroglutamic acid
CCKscholecystokinin
a b w xLutz et al., Eur. J. Biochem., submitted. Synthesized according to procedures described in 5 .
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Fig. 2. NaI quenching of: I, DP-gastrin in buffer and ‘, in
LUV’s.
liposomes were suspended in HEPESrMES buffer
pH 7.4. An excitation wavelength of 295 nm was
used. The contribution of the Raman scattering peak
at 238 nm was discounted using LUVs as back-
ground.
2.9. Leakage
Aqueous content leakage from liposomes was de-
w xtermined using the ANTS-DPX assay 15 . Films
were hydrated with 12.5 mM ANTS, 45 mM DPX,
68 mM NaCl and 10 mM TES at pH 7.4. After
making LUV’s of approximately 100 nm diameter by
extrusion, the liposomes were separated from un-
Table 2
Tryptophan fluorescence at 378C in HEPESrMES buffer pH 7.4
aPeptide LUV’s Emission maximum
w x w x  .mM mM nm
DP-gastrin 0.9 0 350
0.9 50 348
50 1 100 348
DM-gastrin 0.9 0 350
0.9 50 348
 .NL-HG 1–17 150 0 353
150 1 500 353
 .DM-gastrin 7–17 131 0 344
131 1 500 344
DM-CCK 0.9 0 352
0.9 50 345
a LUV’s composed of egg PE-5% GD1a
trapped dye by passage through Sephadex G-75. Lipid
was collected in the void volume and the concentra-
tion was determined by phosphate analysis. The fluo-
rescence assay was performed in 2 ml of 10 mM
TES, 0.15 M NaCl, 0.1 mM EDTA, pH 7.4, at 378C.
Fluorescence was recorded as a function of time
using an excitation wavelength of 360 nm and an
emission wavelength of 530 nm. Leakage was initi-
ated by adding 0.9 mM lipopeptide to 50 mM LUV’s
in the cuvette. The value for 100% leakage was
obtained by adding 40 ml of 10% Triton X-100
Fig. 3. Inhibition of fusion of Sendai virus with liposomes by DP-gastrin at 378C. R18 dequenching curves for 50 mM LUV’s of egg PE
 .  .  .  .  .with 5% G containing the following concentrations of DP-gastrin: 1 2.7 mM, 2 1.8 mM, 3 0.9 mM, 4 0.45 mM, 5 0 mM.D1a
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approximately 10 min after measurements were initi-
ated.
3. Results
3.1. Tryptophan fluorescence
There are two tryptophan residues, at positions 3
and 13, in the lipogastrins and one, at position 5, in
 .the cholecystokinin chain Table 1 . In buffer all
lipopeptides show an emission maximum at 350 nm,
indicating aqueous exposure of the tryptophan
 .residues. The shorter lipopeptide DM-gastrin 7–17
is an exception, with a slight blue shift in buffer
 .Table 2 . The presence of LUV’s also causes a small
or a negligible blue shift. This indicates that the
tryptophans remain exposed to the aqueous environ-
ment. The peptide NL-HG, lacking a hydrophobic
tail, retains a maximum emission wavelength of 353
nm both in the presence and absence of LUV’s.
Fig. 4. Temperature dependence of the R18 dequenching of 0.9
mM DP-gastrin added to 12.5 mM LUV’s composed of egg PE
 .  .  .with 5% G . 1 DP-gastrin at 258C, 2 LUV’s at 258C, 3D1a
 .  .DP-gastrin at 378C, 4 DP-gastrin at 458C, 5 LUV’s at 378C,
 .6 LUV’s at 458C.
Table 3
Bilayer to hexagonal phase transition shifts in DiPoPE
a  .Slope 8Crmol fraction
NL-HG 180" 1
DM-AAe 133" 14
DM-E y101" 145
DM-gastrin 500" 35
DP-gastrin 1 100"106
DM-CCK 1 200"190
a Slope of a plot of T vs. mol fraction of peptide or lipopeptideH
added.
Trp fluorescence of DP-gastrin was also measured
after successive additions of 10 ml of NaI containing
.0.5 M of Na S O to prevent iodide oxidation in2 2 3
 .HEPES-MES buffer pH 7.4 Fig. 2 . The quenching
of the Trp fluorescence was the same in the presence
and absence of vesicles.
3.2. DSC
DM-gastrin, DP-gastrin, and DM-CCK were the
most powerful stabilizers of the bilayer phase relative
Fig. 5. R18 dequenching curves for 50 mM LUV’s composed of
 .  .egg PE with 5% G with added 1 2 mM DM-gastrin, 2 5D1a
 .  .  .  .mM DM-gastrin 9–17 , 3 5 mM DM-gastrin 7–17 , 4 6 mM
 .  .  .DM-gastrin 11–17 , 5 LUV’s of egg PE with 5% G , 6 2D1a
 .  .mM NL-HG, 7 12 mM DM-E . DM-gastrin 9–17 and DM-5
 .gastrin 11–17 required some methanol to remain in solution.
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 .to the inverted hexagonal phase H of DiPoPE. TheII
peptide NL-HG as well as the short lipopeptide DM-
AAe, had small positive slopes in comparison, while
DM-E had a negative slope, making it a weak5
 .hexagonal phase promoter Table 3 .
3.3. Sendai ˝irus fusion
DP-gastrin is a potent inhibitor of Sendai virus
fusion to LUV’s composed of egg PE with 5% GD1a
 .Fig. 3 . Viral fusion proceeds more rapidly at higher
temperatures, but at each temperature tested, 1.8
 .mol% of DP-gastrin causes potent inhibition Fig. 4 .
The curves of viral fusion kinetics are determined by
the affinity of the virus for the target liposome, the
final extent of fusion as well as the first order rate for
fusion of the bound virus to the target liposome. We
have analyzed the kinetics of the fusion reaction
using several ratios of virus to liposome, as well as
measuring the final extents of fusion after incubation
at the indicated temperature for 20 h. We find that at
all temperatures the DP-gastrin has a marked effect in
reducing the final extent of fusion as well as lowering
 .the fusion rate constant, f Table 4 .
We have also studied the effect on virus-liposome
fusion of a variety of lipopeptides and free peptide
 .structurally related to DP-gastrin Fig. 5 . DP-gastrin
 .is a 16 amino acid peptide residues 2–17 of gastrin
covalently linked at its N-terminus to the DP anchor
 .Fig. 1 . The homologous lipid anchor DM-gastrin,
has about the same inhibitory potency as DP-gastrin.
Attaching partial sequences of gastrin, truncated at
the amino terminus and lacking 1, 3 and 5 Glu’s in
their sequence, to the DM lipid anchor DM-gastrin
 .  .  .7–17 , DM-gastrin 9–17 and DM-gastrin 11–17 ,
.respectively , results in peptides with lower potency
 .to inhibit Sendai fusion Fig. 5 . These truncated
sequences could not be studied comparatively in great
detail due to their insolubility in water, requiring
differing amounts of methanol for keeping them in
solution. Attaching the oligopeptide Glu-Glu-Glu-
Glu-Glu to the DM anchor produces a lipopeptide
which actually promotes fusion somewhat as would
be expected from its small bilayer destabilizing ef-
.fect, observed by DSC . The free gastrin peptide,
with no lipid anchor as well as DM-AAe, have only a
very small effect on Sendai fusion with LUV’s.
We have also tested DM-CCK, a lipopeptide with
Table 4
Effect of 1.8 mol% DP-gastrin on sendai virus fusion with egg PE containing 5 mol% GD1a
 .A Final extents of fusion
Composition Temperature % Virions capable of
 .of LUV’s 8C fusing
 .Control 25 55 "10
 .qDP-gastrin 25 20 " 5
 .Control 37 68 "10
 .qDP-gastrin 37 35 " 5
 .Control 45 72 "10
 .qDP-gastrin 45 38 " 5
a .B Kinetic parameters
y1 y1 y1 y1 .  .  .  .Composition Temperature 8C C M s f s D s
7 y4Control 25 4=10 5=10 0.005
7 y4qDP-gastrin 25 4=10 2=10 0.005
7Control 37 6=10 0.0035 0.01
7qDP-gastrin 37 5=10 0.001 0.01
7Control 45 7=10 0.004 0.015
7qDP-gastrin 45 7=10 0.002 0.015
Ca Kinetic parameters defined according to the scheme which describes the initial events in virus-liposome fusion: virusq liposome |
Df
w xvirus-liposome “ fusion product. See Nir et al. 13 for a more complete description. The estimated error is 25% for C and f and 50%
for D.
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Fig. 6. Comparison of inhibition of Sendai virus fusion when
adding 0.9 mM lipopeptides to 12.5 mM LUV’s composed of egg
 .  .  .PE with 5% G at 378C. 1 no addition, 2 DM-CCK, 3D1a
 .DP-gastrin, 4 DM-gastrin.
eight amino acid residues attached to the DM anchor
 .see Table 1 . The sequence is such that the six
carboxy-terminal amino acids of DM-CCK corre-
spond to the six carboxy-terminal amino acids of the
gastrin lipopeptides used in this study. The DM-CCK
 .proved to be a strong bilayer stabilizer Table 3 and
also an inhibitor of Sendai virus fusion. Its fusion
inhibitory power is somewhat lower than that of
 .DP-gastrin or DM-gastrin, however Fig. 6 . For
example, at 378C and after 24 h, 60% of fusion
occurred for 12.5 mM LUV’s, 44% for 0.9 mM
DM-CCK, 38% for 0.9 mM DP-gastrin and 24% for
0.9 mM DM-gastrin, added respectively to 12.5 mM
LUV’s in cuvette. These trends are maintained for all
concentrations of LUV’s and their reproducibility in
the same batch of virus is within 15%.
To test whether the lipopeptides acted on the virus
or on the target membrane, Sendai virus was incu-
bated with 0.9 mM DP-gastrin or DM-gastrin for 10
min at 378C. Then an aliquot of this mixture was
added to the fluorimeter cuvette containing 50 mM
LUV’s in 2 ml HEPESrMES buffer pH 7.4, so that
 .the final concentration of virus 5 mg would corre-
spond to that of a standard fusion assay. Fluorescence
dequenching was then followed as a function of time.
No inhibition of fusion was seen in this case, indicat-
ing that lipogastrins had to be incorporated into the
target membrane to exert their inhibitory effect on the
virus.
3.4. Leakage
No leakage was observed with this vesicle system,
with or without added lipogastrins, in the first hour
following 15 min of initial thermal equilibration to
378C. A small amount of leakage was observed after
20 h of incubation either with or without lipogastrin.
4. Discussion
Enveloped viruses must fuse with a cellular mem-
brane for infectivity. A strategy to inhibit the infectiv-
ity of these viruses is to block membrane fusion by
altering the surface properties of target membranes.
We have studied the fusion of Sendai virus to large
unilamellar vesicles made of egg phos-
 .phatidylethanolamine PE with 5 mol%, G withD1a
or without the addition of 1.8 mol% of a lipogastrin.
w xThe octadecylrhodamine lipid dilution assay 12 was
used to monitor the overall kinetics of viral fusion.
The DP-gastrin greatly reduced the apparent rate of
fusion. The fusion kinetics were analyzed to separate
the rate constants of association and dissociation of
the virus with the target membrane, as well as the
rate constant for membrane fusion. Addition of 1.8
mol% DP-gastrin reduces the fusion rate constant
3.5-fold at 378C without affecting the reversible bind-
 .ing of the virus to the target liposome Table 4 .
There is also a 2-fold decrease in the final extent of
fusion, a measure of the fraction of virus that is
w xbound in a manner that can proceed to fusion 16 .
DP-gastrin is a negatively charged lipopeptide. It has
been observed that the final extents of membrane
fusion are reduced upon incorporating in the target
w xmembrane anionic amphiphiles that raise the T 18 ,H
 .such as DP-gastrin Table 3 . The negatively charged
amphiphile, DM-E , which lowers T , does not re-5 H
 .duce the final extent of fusion not shown . It is less
( )R.F. Epand et al.rBiochimica et Biophysica Acta 1327 1997 259–268 267
common for an amphiphile to lower the actual fusion
w xrate constant, f. However, certain amphiphiles 3,18 ,
w xas well as the lipid-anchored polymer LPG 7 , also
have this property.
We have begun to evaluate the factors contributing
to the inhibitory action of DP-gastrin. We have also
studied the free gastrin peptide NL-HG, as well as the
lipid anchor itself. Neither of these components of
 .DP-gastrin had any viral inhibitory activity Fig. 5 .
In addition, forms of lipogastrin truncated from the
amino terminus had either lower or no inhibitory
activity. The truncated gastrins, the free peptide and
the lipid anchor, all had weaker effects compared
 .with DP-gastrin in raising T Table 3 . The in-H
hibitory effect of DP-gastrin does not exhibit a high
degree of specificity. Although the truncated peptides
were weaker, they were also inhibitory. In addition,
 .DM-CCK was also inhibitory Fig. 6 . However, not
all lipopeptides exhibit significant inhibitory action.
The lipopeptide, a-factor, which raises T by 217"H
w x14 degreesrmol fraction lipopeptide 2 is a much
weaker bilayer stabilizer than DP-gastrin. The a-fac-
tor is not a potent inhibitor of viral fusion unpub-
.lished observations . The peptide anchored to the
farnesyl moiety of a-factor is much more hydropho-
bic than is either gastrin or CCK. Despite these
correlations, we recognize that other factors also
contribute to inhibition of viral fusion and that the
relationship between fusion inhibition and the in-
crease in T is not quantitative. For example, DM-H
CCK is more effective in raising T but is a slightlyH
weaker inhibitor of Sendai fusion than DM-gastrin.
We have also considered the role of steric interfer-
ence. Among the lipopeptides used, the greatest steric
interference should occur with DP-gastrin. However
we have calculated that the maximal protrusion of
this lipopeptide from the membrane surface when it
˚is a fully extended chain, is only 50 A, less than half
˚of the 120 A that the F-protein protrudes from the
 .membrane Fig. 7 . Alternatively if the peptide cov-
ered the surface of the liposome, the cross-sectional
surface area of the peptide would be sufficient to
cover all of the lipid. However, we believe this
arrangement to be unlikely since fluorescence and
CD measurements show the DP-gastrin to be devoid
of secondary structure and be exposed to an aqueous
w xenvironment 6 . In addition, the Pro residue and the
sequence of five Glu residues would be expected to
Fig. 7. Scale model of a Sendai virion approaching a LUV
containing DP-gastrin. Model of a virion, with protein spikes
˚ ˚protruding 120A, approaching a LUV 1000 A in diameter repre-
 .sented here with evenly distributed 5% G v moleculesD1a
˚  .protruding 25A, and 1.8% DP-gastrin B molecules protruding
˚about 50A from the surface. The representation illustrates that the
relative size and membrane surface density of lipogastrin still
allows access of the viral spike proteins to the target membrane.
 .The size of the extended gastrin 2–17 chain was calculated
using the Biograf Program, V3.0, Molecular Simulations Den-
˚ ˚ .sity s4 dotsrA, van der Waals scales0.89 A .
cause the peptide to protrude more from the mem-
brane surface. It appears, as well, that flexible poly-
mers tethered to the membrane surface do not inhibit
viral fusion. Thus, glycophorin, a sialoglycoprotein
receptor for Sendai which possesses a 25 kDa extra-
cellular portion, does not appear to show any steric
w xinhibition, even at high mol fractions 19 . Thus
lipogastrins provide novel inhibitors of viral fusion
whose likely mechanism is to prevent the membrane
bilayer from forming highly curved structures re-
quired as intermediates in membrane fusion. Lipogas-
trin inhibits not only Sendai fusion to liposomes but
also HIV-induced syncytia formation unpublished
.observation .
( )R.F. Epand et al.rBiochimica et Biophysica Acta 1327 1997 259–268268
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